Adagene(ADAG)
JIANGSU, China
BiotechnologyFocus: Antibody discovery & engineering
Adagene is a life sciences company focused on Antibody discovery & engineering.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Phase 1
Clinical Trials (1)
NCT05277402ADG116 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Phase 1Phase 1
Clinical Trials (1)
NCT05614258Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors
Phase 1ADG106
Solid TumorClinical Trials (1)
NCT03802955Study of ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma
Phase 1Phase 1
Clinical Trials (1)
NCT03707093Study of CD137 Agonist ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma
Phase 1Phase 1
Clinical Trials (1)
NCT04501276A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients
Phase 1ADG116
Solid TumorClinical Trials (1)
NCT04111445Study of ADG116 in Patients With Advanced/Metastatic Solid Tumors
Phase 1Phase 1/2
Clinical Trials (1)
NCT05236608A Study to Evaluate the Combination of Nivolumab With ADG106 in Metastatic NSCLC
Phase 1/2Phase 1/2
Clinical Trials (1)
NCT05405595ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Phase 1/2ADG106 injection
Solid TumorClinical Trials (1)
NCT04775680Study of ADG106 In Combination With PD-1 Antibody In Advanced or Metastatic Solid Tumors and/or Non Hodgkin Lymphoma
Phase 1/2Phase 1/2
Clinical Trials (1)
NCT05275777A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer
Phase 1/2Atezolizumab
Advanced Liver CancersPembrolizumab & ADG106
Advanced Solid TumorClinical Trials (1)
NCT05491083Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer
Phase 1/2ADG126 Mono
Advanced/Metastatic Solid TumorsClinical Trials (1)
NCT04645069ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors
Phase 1/2Phase 2
Clinical Trials (1)
NCT06846268Neoadjuvant ADG126 and Pembrolizumab in Locally Advanced Colorectal Cancer
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 13 clinical trials
Top TAs: Oncology
Publications: 10 in PubMed